Sleep medication for cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a sleep medication called lemborexant can help people with moderate to severe cannabis use disorder. The idea is that improving sleep might reduce cannabis cravings and use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a moderate to severe cannabis use disorder.
- You need to be able to read and write in English.
- You cannot be allergic to lemborexant (the study drug).
- You must not have taken another sleep medication that works in the same way in the last 3 months.
- You cannot be in another medication trial right now or have been in one in the past 12 weeks.
- You must not have certain sleep problems like narcolepsy, sleep apnea, or restless leg syndrome.
- You cannot be currently receiving treatment for cannabis use disorder.
- You must not have had a hospital visit or ER visit related to cannabis use in the past.
- You cannot have severe liver problems or certain other medical or mental health conditions (like epilepsy or recent suicidal thoughts).
- You must not be pregnant, nursing, or planning to become pregnant, and you must agree to use birth control if you can become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This study looks at how cannabis affects sleep, daily rhythms, and sensitivity to light in young adults. You would either stop using cannabis for 4 weeks (if you are a regular user) or serve as a non-user control, to compare sleep patterns.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.